Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01644552 · ClinicalTrials.gov registry record
Positive Angle Kappa
A clinical trial of Aniridia, sponsored by University of Minnesota.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT01644552: Completed study of Aniridia, sponsored by University of Minnesota.
NCT01644552 is a study of Aniridia that has completed, run by University of Minnesota. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01644552, a study of Aniridia, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with aniridia have positive angle kappas.
Conditions Studied
Study Locations (1)
Minnesota
- University of Minnesota Dept of ophthalmlogy - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-09 |
What the finished NCT01644552 record still lists
NCT01644552 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 1 condition, with Aniridia appearing as the primary indexed condition, and to 0 interventions.
NCT01644552 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01644552 about?
NCT01644552 is a clinical study titled "Positive Angle Kappa". Patients with aniridia have positive angle kappas.
What is the current status of trial NCT01644552?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2010-08. Estimated completion is 2011-09.
What conditions does trial NCT01644552 study?
This clinical trial studies the following conditions: Aniridia.
Who is sponsoring clinical trial NCT01644552?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01644552 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aniridia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia